Which closed-end funds own Takeda Pharmaceutical?
2 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $8M. Security type: debt security. Country: Japan. CUSIP 874060AX4 · ISIN US874060AX48.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BTZ BlackRock Credit Allocation Income Trust | Taxable Bonds | 0.64% | $7.5M | 8,270,000 par | $1.2B | 10.2% discount | Jun 30, 2026 |
| BHK BlackRock Core Bond Trust | Investment Grade | 0.07% | $454K | 500,000 par | $688M | 7.8% discount | Jun 30, 2026 |
2 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “TAKEDA PHARMACEUTICAL” → · Compare two funds’ portfolios →